The antipyretic effect of pyrazolone derivatives and salicylates on fever induced with leukocytic or bacterial pyrogen.
D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D000983:Antipyrine / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology; D002490:Central Nervous System / Q000187:drug effects; D004336:Drug Antagonism; D004926:Escherichia coli; D005334:Fever / Q000139:chemically induced / Q000517:prevention & control*; D006041:Goats; D066298:In Vitro Techniques; D007962:Leukocytes; D008070:Lipopolysaccharides; D008744:Methylamines / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D011720:Pyrazoles / Q000494:pharmacology*; D011749:Pyrogens; D011817:Rabbits; D012459:Salicylates / Q000494:pharmacology*; D012486:Salmonella typhimurium; D013451:Sulfonic Acids / Q000494:pharmacology
D000700:Analgesics; D008070:Lipopolysaccharides; D008744:Methylamines; D011720:Pyrazoles; D011749:Pyrogens; D012459:Salicylates; D013451:Sulfonic Acids; D010653:Phenylbutazone; D001241:Aspirin; D000983:Antipyrine